WORLDCOIN-FOUNDATION
13.12.2023 16:03:32 CET | Business Wire | Press release
Worldcoin today introduced a protocol update - World ID 2.0, a more powerful, privacy preserving “humanness” digital passport equipped with exciting app integrations* and a suite of new features. Humanness verification services are expanding in Mexico and Singapore, increasing global access to World ID 2.0.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20231213314816/en/
The World ID 2.0 Passport. (Photo: Business Wire)
World ID 2.0 makes it easier to distinguish between bots and verified humans online while preserving privacy with popular apps and services with new pre-built integrations. The protocol will be integrated with popular e-commerce, gaming and social media platforms including: Shopify, Mercado Libre, Minecraft, Reddit and Telegram.
Prove personhood, not identity
The rapid global advancement of artificial intelligence has accelerated the need to differentiate between human- and AI-generated content online. As reported by CNBC, retailers are losing an estimated $100 billion per year from return fraud, bots and coupon stacking. Meanwhile, the digital gaming industry struggles to combat bots impacting the real number of humans playing online and have been alleged to fraudulently beat humans in competitive games.
World ID aims to provide a decentralized digital identity layer that enables anonymous actions for the benefit of every unique human online. With the humanness digital passport, individuals can verify to an app or service that they are human without disclosing their identity, and brands can ensure that their offerings and services are being used as intended. World ID 2.0 also offers new verification levels to provide developers choice when implementing humanness verification requirements into their apps or services.
App integrations deliver greater utility
Users and businesses benefit from World ID. New integrations with apps like Shopify, Telegram, Minecraft, Reddit and Mercado Libre, alongside existing integrations with apps including Discord, Talent Protocol and Okta’s Auth0, mean individuals can quickly and easily verify their humanness on the platforms they use every day. And with a new, high-performance developer platform enabling builders to easily integrate “Sign in with World ID” onto their app, new integrations are being added every week, all visible on the new Worldcoin App Store.
New verification levels offer increased access and flexibility
Nearly five million people globally now have a World ID, and more than 2.5 million have verified their humanness at an Orb so they can fully utilize their World ID.
With its new verification levels, World ID 2.0 introduces more ways for people to use their World ID based on the security needs of the application and to ensure individuals are not sharing more information than they need or want for a given application. From device verification for high convenience and accessibility all the way to Orb verification with additional face authentication for high security use cases, there’s now a way for everyone to use their World ID even if they haven’t yet had the opportunity to verify at an Orb.
How to get a World ID
Obtaining a World ID is as simple as downloading a compatible wallet, starting with the World App which is designed to support 94.5% of the iOS and 98.2% of Android smartphones in use today. Initial verification of a World ID offers a baseline level of protection with Device Auth and an Orb-verified World ID provides enhanced utility for applications or services requiring higher security and verification. Visit https://worldcoin.org/find-orb or check the World App to find an Orb verification location near you.
A look at Worldcoin momentum and expansion
Interest in access to Worldcoin and proof of personhood technologies like World ID is continuing to grow globally. In 2023, World ID verifications jumped from under a million in January to more than 2.5 million by the end of November. Additional Orb locations are also opening in both new and existing cities to help make sure everyone who wants to be a part of the Worldcoin community can do so. Mexico and Singapore join the list of locations where individuals can now find Orbs.
About the Worldcoin Foundation
The Worldcoin Foundation, a steward of the Worldcoin protocol until it is self-sufficient, aims to realize more inclusive, fair and just institutions of governance and of the global digital economy.
About the Worldcoin Protocol
The Worldcoin protocol is intended to be the world’s largest, most inclusive identity and financial public utility and to be accessible by everyone. Worldcoin was originally conceived by Sam Altman, Alex Blania and Max Novendstern. The Worldcoin protocol is designed to empower individuals and organizations around the world with the tools they need to participate in the digital economy and advance humanity's progress. Find out more about Worldcoin at www.worldcoin.org, on Twitter/X, Discord, YouTube and Telegram.
*World ID integrations do not imply World ID is an official product, or a partnership, sponsorship, or endorsement, of the companies whose products were integrated, such as Discord, Mercado Libre, Microsoft, Mojang, Reddit, and Shopify.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20231213314816/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release
A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us
Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release
Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas
ICE Brent and ICE WTI Perpetual Futures to Launch on OKX22.5.2026 14:30:00 CEST | Press release
OKX, a blockchain technology and trading company serving more than 120 million customers globally,and Intercontinental Exchange (NYSE: ICE), one of the world's leading providers of financial market technology and data powering global capital markets including the New York Stock Exchange, today announced plans for OKX to launch perpetual futures based on ICE's Brent Crude and WTI Crude energy benchmarks. The products are expected to be available to trade on OKX’s platform in jurisdictions where OKX is licensed to offer perpetual futures products. The new OKX contracts represent a major step forward in expanding regulated access to global commodity markets through digital asset infrastructure. This first product collaboration between OKX and ICE comes after the companies established a strategic relationship in March 2026. ICE operates some of the world’s leading exchanges, clearing houses and market data services across energy, commodities, fixed income and equities markets. ICE’s future
Enhertu® Recommended for Approval in the EU by CHMP for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors22.5.2026 14:00:00 CEST | Press release
Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+) solid tumors who have received prior treatment and who have no satisfactory treatment options. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from patients with HER2 positive (IHC 3+) tumors in three phase 2 trials including DESTINY-PanTumor02,DESTINY-Lung01 andDESTINY-CRC02 where Enhertu demonstrated clinically meaningful responses across a broad range of tumors. The recommendation will now be reviewed by the European Commission, which has the authority
Future Health Challenge Awards USD 300,000 to Early Detection and Population Health Sensing Tools on Sidelines of World Health Assembly22.5.2026 13:45:00 CEST | Press release
Global teams recognised in the Future Health Challenge for solutions designed to detect health risks earlier and support faster health system decisions Future Health – A Global Initiative by Abu Dhabi and MIT Solve announce the winners of the inaugural Future Health ChallengeWinning solution equips frontline health workers in low-resource settings with mobile clinical decision-support tools, enabling earlier detection and more effective care deliveryTeams competed for a USD 200,000 grand prize and two USD 50,000 runner-up awards on the sidelines of the 79th World Health Assembly in GenevaWinners recognised for solutions advancing anticipatory, data-driven health systems Three global teams developing early detection and real-time population health monitoring solutions have secured a total of USD 300,000 on the sidelines of the 79th World Health Assembly. The winning solutions address critical challenges in early detection, continuous population insight and more timely decision making, s
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom